Cigna Group $CI Shares Acquired by Wealthfront Advisers LLC

Wealthfront Advisers LLC boosted its stake in shares of Cigna Group (NYSE:CI) by 28.2% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 29,267 shares of the health services provider’s stock after purchasing an additional 6,434 shares during the quarter. Wealthfront Advisers LLC’s holdings in Cigna Group were worth $9,675,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Flaharty Asset Management LLC acquired a new position in Cigna Group during the 1st quarter worth $28,000. 1248 Management LLC acquired a new position in Cigna Group during the 1st quarter worth $29,000. Activest Wealth Management boosted its position in Cigna Group by 360.0% during the 1st quarter. Activest Wealth Management now owns 92 shares of the health services provider’s stock worth $30,000 after acquiring an additional 72 shares during the period. Princeton Global Asset Management LLC boosted its position in Cigna Group by 115.6% during the 2nd quarter. Princeton Global Asset Management LLC now owns 97 shares of the health services provider’s stock worth $32,000 after acquiring an additional 52 shares during the period. Finally, Retirement Wealth Solutions LLC boosted its position in Cigna Group by 74.1% during the 2nd quarter. Retirement Wealth Solutions LLC now owns 101 shares of the health services provider’s stock worth $33,000 after acquiring an additional 43 shares during the period. Institutional investors and hedge funds own 86.99% of the company’s stock.

Insiders Place Their Bets

In other news, insider Nicole S. Jones sold 28,526 shares of the business’s stock in a transaction on Friday, August 15th. The stock was sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the sale, the insider directly owned 25,648 shares of the company’s stock, valued at $7,694,400. The trade was a 52.66% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Brian C. Evanko sold 5,368 shares of the business’s stock in a transaction on Friday, October 3rd. The stock was sold at an average price of $300.00, for a total value of $1,610,400.00. Following the sale, the insider directly owned 51,182 shares in the company, valued at $15,354,600. This trade represents a 9.49% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.70% of the stock is owned by insiders.

Cigna Group Stock Down 1.1%

CI opened at $301.84 on Monday. Cigna Group has a one year low of $256.89 and a one year high of $350.00. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.71 and a current ratio of 0.71. The stock’s fifty day moving average is $299.22 and its 200-day moving average is $307.54. The company has a market capitalization of $80.57 billion, a PE ratio of 16.48, a P/E/G ratio of 0.88 and a beta of 0.45.

Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, topping analysts’ consensus estimates of $7.15 by $0.05. The company had revenue of $67.13 billion for the quarter, compared to the consensus estimate of $62.61 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The company’s quarterly revenue was up 11.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $6.72 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, equities analysts predict that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, December 18th. Stockholders of record on Thursday, December 4th will be given a dividend of $1.51 per share. The ex-dividend date of this dividend is Thursday, December 4th. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.0%. Cigna Group’s payout ratio is 32.97%.

Analyst Upgrades and Downgrades

CI has been the subject of a number of analyst reports. Wolfe Research reduced their price target on Cigna Group from $345.00 to $325.00 and set an “outperform” rating for the company in a research report on Wednesday, October 15th. Barclays boosted their price target on Cigna Group from $354.00 to $383.00 and gave the stock an “overweight” rating in a research report on Thursday, September 4th. The Goldman Sachs Group assumed coverage on Cigna Group in a research report on Tuesday, October 14th. They set a “buy” rating and a $370.00 price target for the company. Wells Fargo & Company boosted their price objective on Cigna Group from $340.00 to $354.00 and gave the stock an “equal weight” rating in a research note on Tuesday, October 7th. Finally, Wall Street Zen downgraded Cigna Group from a “buy” rating to a “hold” rating in a research note on Friday, October 3rd. Two analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $369.89.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.